PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Walth-Hummel, A.A. ; Herzig, S. ; Rohm, M.

Nuclear receptors in energy metabolism.

Adv. Exp. Med. Biol. 1390, 61-82 (2022)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Nuclear receptors are master regulators of energy metabolism through the conversion of extracellular signals into gene expression signatures. The function of the respective nuclear receptor is tissue specific, signal and co-factor dependent. While normal nuclear receptor function is central to metabolic physiology, aberrant nuclear receptor signaling is linked to various metabolic diseases such as type 2 diabetes mellitus, obesity, or hepatic steatosis. Thus, the tissue specific manipulation of nuclear receptors is a major field in biomedical research and represents a treatment approach for metabolic syndrome. This chapter focuses on key nuclear receptors involved in regulating the metabolic function of liver, adipose tissue, skeletal muscle, and pancreatic β-cells. It also addresses the importance of nuclear co-factors for fine-tuning of nuclear receptor function. The mode of action, role in energy metabolism, and therapeutic potential of prominent nuclear receptors is outlined.
Impact Factor
Scopus SNIP
Altmetric
3.650
0.143
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Energy Homeostasis ; Glucose And Lipid Metabolism ; Metabolic Syndrome ; Nuclear Receptor-based Therapies ; Transcriptional Co-factors; Growth-factor 21; Farnesoid-x-receptor; Improves Glucose-tolerance; Alpha Gene-expression; Ppar-gamma Activation; White Adipose-tissue; Lxr Inverse Agonist; Muscle-fiber-type; Glucocorticoid-receptor; Skeletal-muscle
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 0065-2598
Zeitschrift Advances in Experimental Medicine and Biology
Quellenangaben Band: 1390, Heft: , Seiten: 61-82 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort New York
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Cancer (IDC)
POF Topic(s) 90000 - German Center for Diabetes Research
30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-501900-257
G-502591-001
G-501900-251
Förderungen Else Kroner-Fresenius Foundation
Deutsche Forschungsgemeinschaft (DFG)
Helmholtz Future Topic Aging and Metabolic Programming (AMPro)
European Association for the Study of Diabetes (EASD)
Helmholtz Association - Initiative and Networking Fund
DOI 10.1007/978-3-031-11836-4_4
WOS ID 001022545900006
Scopus ID 85137856139
PubMed ID 36107313
Erfassungsdatum 2022-09-26
[➜Korrektur melden]